Paperpal Prime Logo

Journal of Aerosol Medicine and Pulmonary Drug Delivery : Impact Factor & More

eISSN: 1941-2703pISSN: 1941-2711

Key Metrics

CiteScore
5.1
Impact Factor
< 5
SNIP
1.19
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Journal of Aerosol Medicine and Pulmonary Drug Delivery

Journal of Aerosol Medicine and Pulmonary Drug Delivery Journal Specifications

Overview
Publisher MARY ANN LIEBERT, INC
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year2008
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Journal of Aerosol Medicine and Pulmonary Drug Delivery ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Journal of Aerosol Medicine and Pulmonary Drug Delivery

Preclinical Development of a Dry Powder Formulation of Loxapine for Intranasal Delivery.
  • 7 Aug 2026
  • Journal of aerosol medicine and pulmonary drug delivery
Letter: Letter to the Editor In Response to Weers et al.
  • 1 Aug 2026
  • Journal of aerosol medicine and pulmonary drug delivery
Letter: Impact of Suboptimal Peak Inspiratory Flow on Exacerbations in Chronic Obstructive Pulmonary Disease Patients Using Dry Powder Inhalers.
  • 23 Jul 2026
  • Journal of aerosol medicine and pulmonary drug delivery
Mucociliary Clearance Following a Next-Generation Propellant Versus Hydrofluoroalkane-134a via Pressurized Metered-Dose Inhaler: A Randomized, Double-Blind, Two-Way Crossover Study in Healthy Adults.
  • 16 Jul 2026
  • Journal of aerosol medicine and pulmonary drug delivery
Toward Next-Generation Propellants: Assessing Lung Deposition of Beclometasone Dipropionate, Formoterol, and Glycopyrrolate Formulated with HFA-152a Using Functional Respiratory Imaging.
  • 16 Jul 2026
  • Journal of aerosol medicine and pulmonary drug delivery
Selecting the Optimal Inhaler in Asthma: Respiratory and Peripheral Muscle Strength as Predictors of DPI and MDI Response.
  • 29 Jun 2026
  • Journal of aerosol medicine and pulmonary drug delivery
Preclinical Development of a Dry Powder Formulation of Loxapine for Intranasal Delivery.
  • 7 Aug 2026
  • Journal of aerosol medicine and pulmonary drug delivery
Letter: Letter to the Editor In Response to Weers et al.
  • 1 Aug 2026
  • Journal of aerosol medicine and pulmonary drug delivery
Letter: Impact of Suboptimal Peak Inspiratory Flow on Exacerbations in Chronic Obstructive Pulmonary Disease Patients Using Dry Powder Inhalers.
  • 23 Jul 2026
  • Journal of aerosol medicine and pulmonary drug delivery
Mucociliary Clearance Following a Next-Generation Propellant Versus Hydrofluoroalkane-134a via Pressurized Metered-Dose Inhaler: A Randomized, Double-Blind, Two-Way Crossover Study in Healthy Adults.
  • 16 Jul 2026
  • Journal of aerosol medicine and pulmonary drug delivery
Toward Next-Generation Propellants: Assessing Lung Deposition of Beclometasone Dipropionate, Formoterol, and Glycopyrrolate Formulated with HFA-152a Using Functional Respiratory Imaging.
  • 16 Jul 2026
  • Journal of aerosol medicine and pulmonary drug delivery
Selecting the Optimal Inhaler in Asthma: Respiratory and Peripheral Muscle Strength as Predictors of DPI and MDI Response.
  • 29 Jun 2026
  • Journal of aerosol medicine and pulmonary drug delivery

FAQs on Journal of Aerosol Medicine and Pulmonary Drug Delivery